Institut Gustave Roussy
OrganisationROR
People
Lead investigator
Sources: openalex.org
Grants and prizes
HORIZON-RIA, ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond, 101288355, €209.9k, 2026–2031, 13 May 2026
ERC-STG, Clonal hematopoiesis in cancer, 101221800, €1.5m, 2026–2031, 12 Nov 2025
HORIZON-TMA-MSCA-DN, Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management, 101227105, €314.7k, 2026–2029, 8 Jul 2025
HORIZON-IA, Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome, 101213916, €90k, 2025–2031, 14 May 2025
Agence Nationale de la Recherche
AAPG2022, Senolysis in Langerhans Cell Histiocytosis, ANR-22-CE14-0024, €273.2k, 2022, 1 Oct 2022
Sources: cordis.europa.eu, openalex.org